About BNJ Biopharma
BNJ Biopharma is a company based in South Korea founded in 2021 by Jae-June Dong was acquired by The Invention Lab in December 2023. BNJ Biopharma operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter South Korea
- Founders Jae-June Dong
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
The Invention Lab
(Dec 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BNJ Biopharma
Detailed funding history for BNJ Biopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BNJ Biopharma
BNJ Biopharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Invention Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
The Invention Lab is recognized as a startup accelerator and seed investment firm.
|
Locked | Locked | Locked |
Investor details for BNJ Biopharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BNJ Biopharma
Investment portfolio details for BNJ Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BNJ Biopharma
Detailed financials for BNJ Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bnj Biopharma Comparisons
Peer comparison for BNJ Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BNJ Biopharma
BNJ Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of BNJ Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bnj Biopharma
Complete news archive for BNJ Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BNJ Biopharma
BNJ Biopharma was founded in 2021.
BNJ Biopharma is headquartered in South Korea.
Jae-June Dong is the current CEO of BNJ Biopharma. They have also founded this company.
BNJ Biopharma was founded in 2021 in South Korea as an AI-based drug development company. Focus is placed on designing anti-cancer drugs through analysis of tumor diversity data. Seed funding was obtained from INNOCUVE, with additional investment recently secured from The Invention Lab. Operations center on biotechnology and pharmaceutical innovation in the region.
BNJ Biopharma's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
BNJ Biopharma has 1 investor. Key investors include The Invention Lab.